Calcium Electroporation for the Treatment of Keloids

• Status: Completed
• Trial end date: 2018-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effect of calcium electroporation on keloids.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Herlev Hospital
• Treatments: Calcium; Calcium, Dietary

Criteria

Inclusion Criteria:

• At least 1 keloid available to electroporation.

• Patient should have been offered standard treatment.

• At least 8 weeks since other keloid treatment.

• Performance status <2 (ECOG).

• Platelet count >50 mia/l

• International Normalized Ratio (INR) <1,2.

• Age >18.

• Patient should be able to understand participants information.

• Signed, informed consent.

Exclusion Criteria:

• Clinically significant coagulopathy.

• Pregnancy or lactation.

• Participation in other clinical trial involving experimental drugs or participation in a clinical trial within 4 weeks before study treatment.